Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Clinical significance of somatic mutation in unexplained blood cytopenia

Blood (2017) 129 (25): 3371–3378.

https://doi.org/10.1182/blood-2017-01-763425

Published: 2017

Includes: Supplemental data

Journal Articles

Predictive Value of Mutation Analysis in the Diagnostic Approach to Patients with Unexplained Cytopenia

Luca Malcovati, MD, Anna Gallì, Erica Travaglino, Ilaria Ambaglio, MD, Ettore Rizzo, Elisabetta Molteni, Chiara Elena, MD, Silvia Catricalà, Elisa Bono, MD, Antonio Bianchessi, MD, Gabriele Todisco, MD, Elisa Rumi, MD, Virginia Valeria Ferretti, Elli Papaemmanuil, PhD, Seishi Ogawa, MD PhD, Mario Cazzola, MD

Blood (2016) 128 (22): 298.

https://doi.org/10.1182/blood.V128.22.298.298

Published: 2016

Journal Articles

SRSF2 Mutations Identify a Distinct Subtype of Myeloid Neoplasm Across Myelodysplastic Syndromes and Acute Myeloid Leukemia

Gabriele Todisco, MD, Anna Gallì, Erica Travaglino, Ettore Rizzo, Elisabetta Molteni, Chiara Elena, MD, Ilaria Ambaglio, MD, Silvia Catricalà, Paolo Bernasconi, MD, Virginia Valeria Ferretti, Luca Malcovati, MD, Mario Cazzola, MD

Blood (2016) 128 (22): 4337.

https://doi.org/10.1182/blood.V128.22.4337.4337

Published: 2016

Journal Articles

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

Blood (2016) 128 (10): 1408–1417.

https://doi.org/10.1182/blood-2016-05-714030

Published: 2016

Includes: Supplemental data

Journal Articles

SF3B1 Mutation Is an Independent Predictor of Parenchymal Iron Overload in Myelodysplastic Syndromes

Ilaria Ambaglio, MD, Valeria Pinto, MD, Domenico Girelli, MD PhD, Chiara Elena, MD, Natascia Campostrini, Daniela Pietra, PhD, Anna Gallì, Erica Travaglino, Mario Cazzola, MD, Gian Luca Forni, MD, Luca Malcovati, MD

Blood (2015) 126 (23): 1678.

https://doi.org/10.1182/blood.V126.23.1678.1678

Published: 2015

Journal Articles

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

Blood (2015) 126 (2): 233–241.

https://doi.org/10.1182/blood-2015-03-633537

Published: 2015

Includes: Supplemental data

Journal Articles

Somatic Mutations of ASXL1 , RUNX1 and SETBP1 Improve Prognostic Stratification of Patients with Chronic Myelomonocytic Leukemia

Chiara Elena, MD, Anna Gallì, PhD, Esperanza Such, PhD, Ulrich Germing, Ettore Rizzo, PhD, Jose Cervera, MD, Elisabetta Molteni, PhD, Esther Schuler, Ilaria Ambaglio, MD, Maria Lopez-Pavia, Silvia Zibellini, PhD, Andrea Kuendgen, MD, Erica Travaglino, Reyes Sancho-Tello, Matteo G Della Porta, MD, Ana Isabel Vicente, Guillermo F. Sanz, MD PhD, Luca Malcovati, MD, Mario Cazzola, MD

Blood (2014) 124 (21): 1915.

https://doi.org/10.1182/blood.V124.21.1915.1915

Published: 2014

Journal Articles

Genetic Determinants of Disease Phenotype and Clinical Outcome in Myelodysplastic Syndromes with Ring Sideroblasts

Blood (2014) 124 (21): 825.

https://doi.org/10.1182/blood.V124.21.825.825

Published: 2014

Journal Articles

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia

Blood (2014) 124 (9): 1513–1521.

https://doi.org/10.1182/blood-2014-03-560227

Published: 2014

Includes: Supplemental data

Journal Articles

Clinical and biological implications of driver mutations in myelodysplastic syndromes

Blood (2013) 122 (22): 3616–3627.

https://doi.org/10.1182/blood-2013-08-518886

Published: 2013

Includes: Supplemental data

Journal Articles

Genetic Determinants Of Disease Phenotype In Myelodysplastic Syndromes

Ilaria Ambaglio, MD, Luca Malcovati, MD, Elli Papaemmanuil, PhD, Anna Gallì, PhD, Matteo G Della Porta, MD, Chiara Elena, MD, Marta Ubezio, MD, Elisa Bono, MD, Matteo C Da Vià, MD, Anna Cattaneo, MD, Erica Travaglino, Rosangela Invernizzi, MD, Peter J. Campbell, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 2755.

https://doi.org/10.1182/blood.V122.21.2755.2755

Published: 2013

Journal Articles

Clinical and Molecular Features Of Myeloid Neoplasms Carrying SRSF2 Mutation

Chiara Elena, MD, Luca Malcovati, MD, Elli Papaemmanuil, PhD, Anna Gallì, PhD, Matteo G Della Porta, MD, Ilaria Ambaglio, MD, Marta Ubezio, MD, Matteo C Da Vià, MD, Elisa Bono, MD, Anna Cattaneo, MD, Erica Travaglino, Rosangela Invernizzi, MD, Peter J. Campbell, PhD, Mario Cazzola, MD

Blood (2013) 122 (21): 1532.

https://doi.org/10.1182/blood.V122.21.1532.1532

Published: 2013

Journal Articles

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

Esperanza Such, Ulrich Germing, Luca Malcovati, José Cervera, Andrea Kuendgen, Matteo G. Della Porta, Benet Nomdedeu, Leonor Arenillas, Elisa Luño, Blanca Xicoy, Mari L. Amigo, David Valcarcel, Kathrin Nachtkamp, Ilaria Ambaglio, Barbara Hildebrandt, Ignacio Lorenzo, Mario Cazzola, Guillermo Sanz

Blood (2013) 121 (15): 3005–3015.

https://doi.org/10.1182/blood-2012-08-452938

Published: 2013

Includes: Supplemental data

Journal Articles

Clonal Analysis of SF3B1 , JAK2 and MPL in Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis

Ilaria Ambaglio, Anna Gallì, Daniela Pietra, Matteo G Della Porta, Marta Ubezio, Matteo C Da Vià, Elisa Bono, Chiara Milanesi, Erica Travaglino, Rosangela Invernizzi, Elli Papaemmanuil, Peter Campbell, Luca Malcovati, Mario Cazzola

Blood (2012) 120 (21): 172.

https://doi.org/10.1182/blood.V120.21.172.172

Published: 2012

Journal Articles

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Blood (2011) 118 (24): 6239–6246.

https://doi.org/10.1182/blood-2011-09-377275

Published: 2011

Includes: Supplemental data

Journal Articles

Somatic Mutation of SF3B1 , a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts

Blood (2011) 118 (21): 3.

https://doi.org/10.1182/blood.V118.21.3.3

Published: 2011

Journal Articles

Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS

Alessandro Corso, MD, Silvia Mangiacavalli, MD, Federica Cocito, MD, Cristiana Pascutto, Cesare Astori, MD, Marzia Varettoni, MD, Ester Orlandi, MD, Patrizia Zappasodi, MD, Silvia Rizzi, MD, Ilaria Ambaglio, MD, Mario Lazzarino, Prof, Mario Cazzola, MD

Blood (2010) 116 (21): 3037.

https://doi.org/10.1182/blood.V116.21.3037.3037

Published: 2010

Journal Articles

Erythroid Activity, Transfusion Iron Overload, and Hepcidin Levels in Patients with Myelodysplastic Syndrome

Luca Malcovati, MD, Matteo G Della Porta, MD, Coby M Laarakkers, MD, Anna Gallì, BSc, Riccardo Albertini, MD, Margherita Maffioli, MD, Ilaria Ambaglio, MD, Erica Travaglino, Rosangela Invernizzi, MD, Remigio Moratti, MD, Dorine W. Swinkels, MD, PhD, Mario Cazzola, MD

Blood (2008) 112 (11): 2676.

https://doi.org/10.1182/blood.V112.11.2676.2676

Published: 2008

Journal Articles

Myelodysplastic Syndrome (MDS)-Specific Comorbidity Index for Predicting the Impact of Extra-Hematological Comorbidities on Survival of Patients with MDS

Matteo G Della Porta, MD, Andrea Kuendgen, MD, Luca Malcovati, MD, Esther Zipperer, MD, Cristiana Pascutto, PhD, Erica Travaglino, Margherita Maffioli, MD, Ilaria Ambaglio, MD, Rosangela Invernizzi, MD, Ulrich Germing, MD, Mario Cazzola, MD

Blood (2008) 112 (11): 2677.

https://doi.org/10.1182/blood.V112.11.2677.2677

Published: 2008

NARROW

Clinical significance of somatic mutation in unexplained blood cytopenia

Predictive Value of Mutation Analysis in the Diagnostic Approach to Patients with Unexplained Cytopenia

SRSF2 Mutations Identify a Distinct Subtype of Myeloid Neoplasm Across Myelodysplastic Syndromes and Acute Myeloid Leukemia

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

SF3B1 Mutation Is an Independent Predictor of Parenchymal Iron Overload in Myelodysplastic Syndromes

SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts

Somatic Mutations of ASXL1 , RUNX1 and SETBP1 Improve Prognostic Stratification of Patients with Chronic Myelomonocytic Leukemia

Genetic Determinants of Disease Phenotype and Clinical Outcome in Myelodysplastic Syndromes with Ring Sideroblasts

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia

Clinical and biological implications of driver mutations in myelodysplastic syndromes

Genetic Determinants Of Disease Phenotype In Myelodysplastic Syndromes

Clinical and Molecular Features Of Myeloid Neoplasms Carrying SRSF2 Mutation

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

Clonal Analysis of SF3B1 , JAK2 and MPL in Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Somatic Mutation of SF3B1 , a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts

Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS

Erythroid Activity, Transfusion Iron Overload, and Hepcidin Levels in Patients with Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)-Specific Comorbidity Index for Predicting the Impact of Extra-Hematological Comorbidities on Survival of Patients with MDS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only